356 related articles for article (PubMed ID: 22376049)
1. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications.
Singh SK; Singh MK; Kulkarni PP; Sonkar VK; Grácio JJ; Dash D
ACS Nano; 2012 Mar; 6(3):2731-40. PubMed ID: 22376049
[TBL] [Abstract][Full Text] [Related]
2. Comment on "amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications".
Pei X; Wang J; Wan Q
ACS Nano; 2014 Mar; 8(3):1966. PubMed ID: 24660818
[No Abstract] [Full Text] [Related]
3. Thrombus inducing property of atomically thin graphene oxide sheets.
Singh SK; Singh MK; Nayak MK; Kumari S; Shrivastava S; Grácio JJ; Dash D
ACS Nano; 2011 Jun; 5(6):4987-96. PubMed ID: 21574593
[TBL] [Abstract][Full Text] [Related]
4. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
5. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake.
Zhang H; Peng C; Yang J; Lv M; Liu R; He D; Fan C; Huang Q
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1761-7. PubMed ID: 23402618
[TBL] [Abstract][Full Text] [Related]
6. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
[TBL] [Abstract][Full Text] [Related]
7. Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
Kiew SF; Kiew LV; Lee HB; Imae T; Chung LY
J Control Release; 2016 Mar; 226():217-28. PubMed ID: 26873333
[TBL] [Abstract][Full Text] [Related]
8. General and biomimetic approach to biopolymer-functionalized graphene oxide nanosheet through adhesive dopamine.
Cheng C; Li S; Nie S; Zhao W; Yang H; Sun S; Zhao C
Biomacromolecules; 2012 Dec; 13(12):4236-46. PubMed ID: 23152977
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Colloids Surf B Biointerfaces; 2013 May; 105():58-66. PubMed ID: 23352948
[TBL] [Abstract][Full Text] [Related]
10. Graphene and graphene oxide as new nanocarriers for drug delivery applications.
Liu J; Cui L; Losic D
Acta Biomater; 2013 Dec; 9(12):9243-57. PubMed ID: 23958782
[TBL] [Abstract][Full Text] [Related]
11. Biomedical applications of graphene and graphene oxide.
Chung C; Kim YK; Shin D; Ryoo SR; Hong BH; Min DH
Acc Chem Res; 2013 Oct; 46(10):2211-24. PubMed ID: 23480658
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and surface wettability properties of amine functionalized graphene oxide films with varying amine chain lengths.
Shanmugharaj AM; Yoon JH; Yang WJ; Ryu SH
J Colloid Interface Sci; 2013 Jul; 401():148-54. PubMed ID: 23622684
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity profile of highly hydrogenated graphene.
Chng EL; Sofer Z; Pumera M
Chemistry; 2014 May; 20(21):6366-73. PubMed ID: 24711117
[TBL] [Abstract][Full Text] [Related]
14. [Research progress of graphene-based materials in the application to biomedicine].
Jiang H; Wang XM; Wang CS
Yao Xue Xue Bao; 2012 Mar; 47(3):291-8. PubMed ID: 22645751
[TBL] [Abstract][Full Text] [Related]
15. Insight into the Interaction of Graphene Oxide with Serum Proteins and the Impact of the Degree of Reduction and Concentration.
Wei XQ; Hao LY; Shao XR; Zhang Q; Jia XQ; Zhang ZR; Lin YF; Peng Q
ACS Appl Mater Interfaces; 2015 Jun; 7(24):13367-74. PubMed ID: 26029973
[TBL] [Abstract][Full Text] [Related]
16. Reactive graphene oxide nanosheets: a versatile platform for the fabrication of graphene oxide-biomolecule/polymer nanohybrids.
Xu LQ; Zhang B; Chen Y; Neoh KG; Kang ET; Fu GD
Macromol Rapid Commun; 2013 Feb; 34(3):234-8. PubMed ID: 23172613
[TBL] [Abstract][Full Text] [Related]
17. Graphene-based antibacterial paper.
Hu W; Peng C; Luo W; Lv M; Li X; Li D; Huang Q; Fan C
ACS Nano; 2010 Jul; 4(7):4317-23. PubMed ID: 20593851
[TBL] [Abstract][Full Text] [Related]
18. Thrombogenicity and biocompatibility studies of reduced graphene oxide modified acellular pulmonary valve tissue.
Wilczek P; Major R; Lipinska L; Lackner J; Mzyk A
Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():310-21. PubMed ID: 26042719
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Viability of the Respiratory Epithelial Cells Using Functionalized Graphene Oxide.
Park CS; Choi KS; Shin JW; Kim SY
J Nanosci Nanotechnol; 2015 Mar; 15(3):2060-6. PubMed ID: 26413621
[TBL] [Abstract][Full Text] [Related]
20. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Dudek I; Skoda M; Jarosz A; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):195-215. PubMed ID: 26502273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
